We believe that our study will contribute to the understanding of the role of RHBDD1 in ESCC patients and serve as a valuable resource for in-depth exploration of the pathogenesis of ESCC and the identification of potential therapeutic targets in the future. The gene discussed is RHBDD1; the disease is esophageal squamous cell carcinoma.